Search

Your search keyword '"W. Mao"' showing total 59 results

Search Constraints

Start Over You searched for: Author "W. Mao" Remove constraint Author: "W. Mao" Publisher elsevier bv Remove constraint Publisher: elsevier bv
59 results on '"W. Mao"'

Search Results

2. A validation study of a continuous automatic measurement of the mechanical power in ARDS patients

4. Comparison of Hematotoxicity of Pegylated Recombinant Human Granulocyte Colony-Stimulating Factor (PEG-rhG-CSF) Combined with Dual-Agent Concurrent Chemoradiotherapy and Cisplatin Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer

8. A Phase III Prospective Randomized Controlled Clinical Trial for the Efficacy and Safety of Neoadjuvant Chemotherapy Combined With Concurrent Chemoradiotherapy and Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer (Lump ≥4 cm)

9. FP14.11 Icotinib versus Chemotherapy as Adjuvant Treatment for Stage II–IIIA EGFR-Mutant NSCLC (EVIDENCE): A Randomized, Open-Label, Phase 3 Study

10. Design of a cusped field thruster for drag-free flight

11. TL response of LiF:Mg,Cu,P (GR200A and GR207A) exposed to high-energy 12C ions

12. Synthesis and fabrication of silver nanowires embedded in PVP fibers by near-field electrospinning process

13. OA13.06 Final Report of a Prospective Randomized Study on Thoracic Radiotherapy Target Volumes with Radiation Dosimetric and Pathologic Analyses

14. MA14.05 A Randomized Phase III Trial of Fruquintinib Versus Placebo in Patients with Advanced Non-Small Cell Lung Cancer (FALUCA)

15. Adjuvant Intensity-Modulated Radiotherapy with Concurrent Chemotherapy after Radical Surgery for Gastric Cancer at a Municipal Tertiary Comprehensive Hospital in China

16. CRT-200.54 Evaluation of 2-year Clinical Outcomes From Post-market Trials With Everolimus-eluting Cobalt Chromium Stents in Diabetics

17. Contemporary Incidence and Predictors of Stent Thrombosis and Other Major Adverse Cardiac Events in the Year After XIENCE V Implantation

19. A New Era of Prospective Real-World Safety Evaluation

20. Deformation behavior and mechanical properties of polycrystalline and single crystal alumina during nanoindentation

21. Phase III Randomized Study of Preoperative Versus Postoperative Chemoradiotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma

25. Experimental and DFT studies on the DNA-binding trend and spectral properties of complexes [Ru(bpy)2L]2+ (L=dmdpq, dpq, and dcdpq)

26. Improvement in the oxidation resistance of the TiAl-based alloy by liquid-phase siliconizing

27. On the dependence of in-grain subdivision and deformation texture of aluminum on grain interaction

28. JCES 01.10 The Main Treatment Failure Pattern for Completely Resected Stage II–IIIA (N1–N2) EGFR-Mutation Positive Lung Cancer

30. P3.14-004 Pathological Study on the Clinical Target Volume (CTV) in Limited-Stage SCLC for CT-Simulation Based Thoracic Radiotherapy Planning

31. MA 09.01 A Propensity-Matched Analysis of Lobectomy and Stereotactic Body Radiotherapy for Early Stage Non-Small Cell Lung Cancer

32. P3.14-015 A Propensity Matched Analysis of SBRT and Sublobar Resection for Stage I Non-Small Cell Lung Cancer in Patients at High Risk for Lobectomy

33. A Propensity Matched Analysis of Stereotactic Body Radiation Therapy and Sublobar Resection for Stage I Non–small Cell Lung Cancer in Patients at High Risk for Lobectomy

35. TCT-39 Long-term Clinical Outcomes in Real-World Patients with Acute Myocardial Infarction Receiving XIENCE V® Everolimus-Eluting Stents: Four-Year Results from the XIENCE V USA Study

36. 2236 Survival outcomes in patients with locally advanced esophageal squamouscell carcinoma treated with nab-paclitaxel and cisplatin as neoadjuvant chemotherapy

37. Biocontrol of selected soilborne diseases of tomato and pepper plants

38. A Retrospective Study of Shrinking Field Radiation Therapy During Chemoradiation Therapy in Stage III Non-Small Cell Lung Cancer

39. A phase III clinical trial of neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus

40. A Computer System for Skeletal Growth Measurement

41. CLINICAL OUTCOMES IN REAL-WORLD PATIENTS RECEIVING THE XIENCE V® EVEROLIMUS-ELUTING STENT PRESENTING WITH CHRONIC KIDNEY DISEASE: ONE-YEAR RESULTS FROM THE XIENCE V USA STUDY

42. Inhomogeneity of rolling texture in Fe28Al2Cr alloy

43. A coded block adaptive neural network system with a radical-partitioned structure for large-volume Chinese characters recognition

44. Morphological characterization of surface-induced platelet activation

45. 9035 POSTER A National, Multi Center, Randomized, Open-label, Phase II Study of Erlotinib Versus Gemcitabine (GEM) Plus Cisplatin as Neoadjuvant Treatment in Stage IIIA-N2 Non-small-cell Lung Cancer (NSCLC) Patients (pts) With Activating EGFR Mutations (C-TONG 1103)

46. Treatment of smaller coronary vessels with XIENCE V® everolimus-eluting stents in real-world patients: 1-year clinical outcomes from the XIENCE V USA study

48. PRELMINARY CHARACTERIZATION OF A DEDICATED IMAGE-GUIDED SBRT SYSTEM

49. TCT-45 Long Term Safety and Effectiveness of XIENCE V® Everolimus Eluting Coronary Stent System in Real-World Population: Three-Year Clinical Outcomes from the XIENCE V® USA Study

50. Epidermal Growth Factor Receptor Mutation in Small Cell Lung Cancer Patients Detected by Mutant-Enriched Liquidchip Technology from Plasma

Catalog

Books, media, physical & digital resources